Advertisement

Archives of Dermatological Research

, Volume 282, Issue 8, pp 539–543 | Cite as

The effect of hypnotically induced analgesia on flare reaction of the cutaneous histamine prick test

  • R. Zachariae
  • P. Bjerring
Original Contributions

Summary

The effect of psychological pain reduction on the cutaneous inflammatory process was investigated by studying the effect of hypnotically induced analgesia on the flare reaction of cutaneous histamine prick tests. Ten highly hypnotically susceptible volunteers had their cutaneous reactivity against histamine prick tests on both arms measured before hypnosis. Their pain-related brain potentials were measured on the basis of eight argon laser stimulations. These measurements were repeated in the hypnotic condition, where subjects were given repeated suggestions of analgesia in one arm. Final measurements were performed in the post-hypnotic condition. Subjectively felt pain was measured on a visual analogue scale. Results showed a mean reduction in subjectively felt pain of 71.7% compared to the baseline condition. A significant (P<0.01) mean reduction of the evoked potentials was found in the hypnotic analgesic condition compared to both the pre-hypnotic (49.9%) and the post-hypnotic condition (36.9%). A significant difference was measured in the histamine flare area between the pre-hypnotic and the hypnotic analgesic condition (P=0.01−0.02) and between the hypnotic analgesic and the post-hypnotic condition when compared with the control arm. The mean ratio of flare area between the analgesic arm and the control arm was 1.04 (SD, 0.16) in the pre-hypnotic condition, 0.78 (SD, 0.22) in the hypnotic analgesic condition, and 1.37 (SD, 0.49) in the post-hypnotic condition. The results support the hypothesis that higher cortical processes can be involved in the interaction of inflammatory and pain processes.

Key words

Hypnotic analgesia Histamine prick test Brain potentials 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Amadeo M, Yanovski A (1975) Evoked potentials and selective attention in subjects capable of hypnotic analgesia. Int J Clin Exp Hypn 23:200–210Google Scholar
  2. 2.
    Arendt-Nielsen L, Zachariae R, Bjerring P (1990) Quantitative evaluation of hypnotically suggested hyperaesthesia and analgesia by painful laser stimulation. Pain 42:243–251Google Scholar
  3. 3.
    Barber TX (1978) Hypnosis, suggestions, and psychosomatic phenomena: A new look from the standpoint of recent experimental studies. Am J Clin Hypnosis 21:13–27Google Scholar
  4. 4.
    Barber TX (1984) Changing “unchangeable” bodily processes by (hypnotic) suggestions: A new look at hypnosis, cognitions, imagining, and the mind-body problem. In: Sheikh AE (ed) Imagination and healing. Baywood, New York, pp 69–127Google Scholar
  5. 5.
    Barber TX, Cooper BJ (1972) Effects on pain of experimentally induced and spontaneous distraction. Psychol Rep 31:647–651Google Scholar
  6. 6.
    Black S (1963) Inhibition of immediate-type hypersensitivity response by direct suggestion under hypnosis. Br Med J 925–929Google Scholar
  7. 7.
    Cannon JT, Lewis JW, Weinberg VE, Liebeskind JC (1983) Evidence for the independence of brainstem mechanisms mediating analgesia induced by morphine and two forms of stress. Brain Res 269:231–236Google Scholar
  8. 8.
    Casey KL (1973) Pain: a current view of neural mechanisms. Am Scientist 61:194–200Google Scholar
  9. 9.
    Chahl LA (1979) Pain induced by inflammatory mediators. In: Beers RF, Bassett EG (eds) Mechanisms of pain and analgesic compounds. Raven Press, New York, pp 273–284Google Scholar
  10. 10.
    Chapman LF, Godell H, Wolff HG (1959) Augmentation of the inflammatory reaction by activity of the central nervous system. Arch Neurol 1:557–564Google Scholar
  11. 11.
    Clynes M, Kohn M, Lifshitz K (1963) Dynamics and spatial behavior of light evoked potentials, their modification under hypnosis, and on-line correlation in relation to rhythmic components. Ann NY Acad Sci 112:468–508Google Scholar
  12. 12.
    Dubreuil DL, Endler NS, Spanos NP (1987/88) Distraction and redefinition in the reduction of low and high intensity experimentally-induced pain. Imag Cogn Pers 7:155–164Google Scholar
  13. 13.
    Finer B, Graf K (1968) Mechanisms of circulatory changes accompanying hypnotic imagination of hyperalgesia and hypoalgesia in causalgic limbs. Z Gesamte Exp Med 148:1–21Google Scholar
  14. 14.
    Frenk H, Cannon T, Lewis JW, Liebeskind JC (1986) Neural and neurochemical mechanisms of pain inhibition. In: Sternbach RA (ed) The psychology of pain. Raven Press, New York, pp 25–47Google Scholar
  15. 15.
    Fry L, Mason AA, Pearson RSB (1964) Effect of hypnosis on allergic skin responses in asthma and hay-fever. Br Med J 1:1145–1148Google Scholar
  16. 16.
    Goldstein A, Hilgard ER (1975) Failure of the opiate antagonist naloxone to modify hypnotic analgesia. Proc Natl Acad Sci USA 72:2041–2043Google Scholar
  17. 17.
    Hayes RL, Katayama Y (1986) Range of environmental stimuli producing nociceptive suppression: implications for neural mechanisms. In: Kelly DD (ed) Stress-induced analgesia. Ann NY Acad Sci 467:1–13Google Scholar
  18. 18.
    Hilgard ER (1986) Hypnosis and pain. In: Sternbach RA (ed) The psychology of pain. Raven Press, New York, pp 197–222Google Scholar
  19. 19.
    Huston JP, Staubli U (1981) Substance P and its effects on learning and memory. In: Martinez JL et al. (eds) Endogenous peptides and learning and memory processes. Academic Press, New York, pp 521–540Google Scholar
  20. 20.
    Jancso N, Jancso-Gabor A, Szolcsanyi J (1967) Direct evidence for neurogenic inflammation and its prevention by denervation and by pretreatment with capsaicin. Br J Pharmacol 31:138–151Google Scholar
  21. 21.
    Kocher L, Anton F, Reeh PW, Handwerker HO (1987) The effect of carrageenin-induced inflammation on the sensitivity of unmyelinated skin nociceptors in the rat. Pain 29:363–373Google Scholar
  22. 22.
    Levine JD, Clark R, Devor M, Helms C, Moskowitz MA, Basbaum AI (1984) Intraneuronal substance P contributes to the severity of experimental arthritis. Science 226:547–549Google Scholar
  23. 23.
    Lewis JW (1986) Multiple neurochemical and hormonal mechanism of stress-induced analgesia. Ann NY Acad Sci 467:194–204Google Scholar
  24. 24.
    Luttinger D, Hernandez DE, Nemeroff CB, Prange AJ (1984) Peptides and nociception. Int Rev Neurobiol 25:186–241Google Scholar
  25. 25.
    Lynn B (1988) Neurogenic inflammation. Skin Pharmacol 1:217–224Google Scholar
  26. 26.
    Marsden CD (1979) The emotion of pain and its chemistry. CIBA Foundation Symposium 69, pp 305–313Google Scholar
  27. 27.
    Mason AA, Black S (1958) Allergic skin responses abolished under treatment of asthma and hayfever by hypnosis. Lancet I 877–880Google Scholar
  28. 28.
    Melzack R (1986) Neurophysiological foundations of pain. In: Sternbach RA (ed) Psychology of pain. Raven Press, New York, pp 1–24Google Scholar
  29. 29.
    Meyerson BA, Brodin E, Linderoth B (1985) Possible neurohumoral mechanisms in CNS stimulation for pain suppression. Appl Neurophysiol 48:175–180Google Scholar
  30. 30.
    Noel M, Nemeroff CB (1987) The role of nonopioid peptides in pain. Pain Headache 9:194–212Google Scholar
  31. 31.
    Price DD, Barber J (1987) An analysis of factors that contribute to the efficacy of hypnotic analgesia. J Abnorm Psychol 96:46–51Google Scholar
  32. 32.
    Roberts AH, Schuler J, Bacon JG, Zimmermann RL, Patterson R (1975) Individual differences and autonomic control: absorption, hypnotic susceptibility, and the unilateral control of skin temperature. J Abnorm Psychol 84:272–279Google Scholar
  33. 33.
    Shifrin RM, Schneider W (1977) Controlled and automatic information processing: II. Perceptual learning, automatic attending, and a general theory. Psych Rev 84:127–190Google Scholar
  34. 34.
    Shor EC (1963) Norms on the Harvard group scale of hypnotic susceptibility, form A. Int J Clin Exp Hypn 11:39–47Google Scholar
  35. 35.
    Shor RE, Orne EC (1963) Harvard group scald of hypnotic susceptibility, form A. Consult. Psychol. Press, Palp Alto, Calif., USAGoogle Scholar
  36. 36.
    Stacher G, Schuster P, Bauer P, Lahoda R, Schulze D (1975) Effects of suggestion of relaxation or analgesia on pain threshold and pain tolerance in waking and in the hypnotic state. J Psychosom Res 19:259–265Google Scholar
  37. 37.
    Sternbach RA (1982) On strategies for identifying neurochemical correlates of hypnotic analgesia: a brief communication. Int J Clin Exp Hypn 30:251–256Google Scholar
  38. 38.
    Stewart JM, Hall ME (1983) Substance P: The “Yin-yang” of behavior? Peptides 1982. Proceedings 17th European Peptide Symposium. W de Gruyter, Berlin, pp 511–516Google Scholar
  39. 39.
    Watkins LR, Mayer DJ (1986) Multiple endogenous opiate and non-opiate analgesia systems: evidence of their existence and clinical implications. Ann NY Acad Sci 467:273–299Google Scholar
  40. 40.
    Zachariae R, Bjerring P, Arendt-Nielsen L (1989) Modulation of Type I immediate and Type IV delayed immunoreactivity using direct suggestion and guided imagery during hypnosis. Allergy 44:537–542Google Scholar
  41. 41.
    Zachariae R, Arendt-Nielsen L, Bjerring P, Gotliebsen K, Nielsen T (1990) The effect of painful argon laser stimulation on human evoked potentials during hypnotically induced anger and depression. Pain Suppl 5:S233Google Scholar
  42. 42.
    Zamir N, Maixner W (1986) The relationship between cardiovascular and pain regulatory systems. In: Kelly DD (ed) Stress-induced analgesia. Ann NY Acad Sci 467:371–384Google Scholar

Copyright information

© Springer-Verlag 1990

Authors and Affiliations

  • R. Zachariae
    • 1
  • P. Bjerring
    • 2
  1. 1.Institute of PsychologyUniversity of AarhusRisskovDenmark
  2. 2.Department of DermatologyMarselisborg HospitalAarhusDenmark

Personalised recommendations